Anthony Gibney Buys 721% More Aura Biosciences Shares

Investors who take an interest in Aura Biosciences, Inc. (NASDAQ:AURA) should definitely note that insider Anthony Gibney recently paid US$4.90 per share to buy US$245k worth of the stock. We reckon that's a good sign, especially since the purchase boosted their holding by 721%.

Our free stock report includes 2 warning signs investors should be aware of before investing in Aura Biosciences. Read for free now.

Aura Biosciences Insider Transactions Over The Last Year

In fact, the recent purchase by Anthony Gibney was the biggest purchase of Aura Biosciences shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price (US$5.96), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

Happily, we note that in the last year insiders paid US$343k for 70.00k shares. But they sold 81.80k shares for US$674k. In total, Aura Biosciences insiders sold more than they bought over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Aura Biosciences

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Insider Ownership Of Aura Biosciences

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Aura Biosciences insiders own about US$5.1m worth of shares (which is 1.7% of the company). We do generally prefer see higher levels of insider ownership.

What Might The Insider Transactions At Aura Biosciences Tell Us?

It is good to see recent purchasing. On the other hand the transaction history, over the last year, isn't so positive. The transactions over the last year don't give us confidence, and nor does the fairly low insider ownership, but at least the recent buying is a positive. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Aura Biosciences. Be aware that Aura Biosciences is showing 2 warning signs in our investment analysis, and 1 of those is concerning...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.